Eric J. Bow, MD, MSc, D. Bacteriol, FRCPC
Professor, Departments of Medical Microbiology & Internal Medicine
University of Manitoba
Medical Director, Clinical and Academic Services and Infection Control Services
Medical Director, Oncology Programme
Eric J Bow MD is Professor of Medicine and Medical Microbiology at the University of Manitoba, Winnipeg. He graduated from the University of Calgary, and trained in General Internal Medicine, Haematology and Oncology at McMaster University, Clinical Microbiology at the University of Toronto, and in Infectious Diseases at the University of Manitoba. Dr. Bow currently holds positions as Medical Director, Clinical and Academic Services and Infection Control Services, CancerCare Manitoba; and Attending Physician in the Sections of Infectious Diseases and Haematology/Oncology, Department of Internal Medicine, University of Manitoba. He is also an Attending Physician in the Manitoba Blood and Marrow Transplant (MBMT) Programme. From June 2009 to November 2012, Dr. Bow held the position of Medical Director, Oncology Programme, Winnipeg Regional Health Authority. From 1997 to June 2009, he held the positions of Head of the Section of Haematology/Oncology, University of Manitoba, Health Sciences Centre, and St. Boniface General Hospital; and Head, Department of Medical Oncology and Haematology, CancerCare Manitoba; and the position of Director and Chief of Services, GD6 Oncology Unit, Health Sciences Centre, Oncology Program, Winnipeg Regional Health Authority from 1990 to June 2009. Dr. Bow’s research interests have focused upon the prevention and management of bacterial and fungal infections in neutropaenic cancer patients and cytotoxic therapy-induced intestinal epithelial damage in the pathogenesis of these infections. He is currently a member of several Clinical Practice Guidelines panels, including the Infectious Diseases Society of America, American Society of Clinical Oncology, the Centers for Disease Control and Prevention, and the Association for Medical Microbiology and Infectious Diseases Canada; a member of the Steering Committee for the International Mycoses Study Group; a member of the Multinational Association for Supportive Care in Cancer, Mucositis Study Group; and is a member of Council for the International Immunocompromised Host Society.